Harvard Bioscience, Inc. (NASDAQ:HBIO)

CAPS Rating: 5 out of 5

A developer, manufacturer and marketer of a range of specialized products, primarily apparatus and scientific instruments, used to improve life science research at pharmaceutical & biotechnology companies, universities & government laboratories worldwide.

Recs

0
Player Avatar surabayajhonny (46.38) Submitted: 1/25/2013 2:22:08 AM : Outperform Start Price: $4.76 HBIO Score: -2.14

Jim Royal

Featured Broker Partners


Advertisement